The National Agency for Food and Drug Administration and Control, NAFDAC, has vowed to confront the menace of substandard and falsified medicines in the country with the implementation of a pharmaceutical traceability strategy with a view to safeguarding the health of the Nigerian populace.
The Director General, of the Agency, Prof. Mojisola Adeyeye, who dropped the hint at the Traceability workshop in Port Harcourt, Rivers State, said the onerous task of safeguarding the health of the nation is daunting in the face of the chaotic drug distribution system currently existing in Nigeria.
She emphasised that the falsification and diversion of health commodities carry very serious health and economic consequences.
In a statement signed by the NAFDAC Resident Media Consultant in Lagos, Mr Sayo Akintola, Adeyeye reiterated that NAFDAC had developed a 5-Year Traceability Implementation plan in line with the objectives of the Nigeria Pharmaceutical Traceability Strategy to achieve supply chain visibility and strengthen interventions against substandard and falsified medicines by the end of her second term.
She said the development, gazetting, and dissemination of the Traceability of Pharmaceutical products Regulations is essential for the adoption and enforcement of the provisions of the Nigeria Pharmaceutical Traceability Strategy.
The Regulation, accompanied by guidelines and compliance requirements would provide a legal framework to support advocacy for stakeholders to implement traceability in the distribution of pharmaceuticals or supply chains.
Further, Adeyeye noted that the participation of relevant stakeholders during the drafting of the Traceability Regulation is important to ensure understanding among stakeholders of the provisions and to welcome feedback, with the goal of improving compliance.